Mauritius aims to position itself as a Medical and Pharmaceutical hub

The Republic of Mauritius is gearing towards positioning itself as a Medical and Pharmaceutical hub. The development of the pharmaceutical industry in Mauritius is a key component of the government’s economic diversification strategy.

In this respect, the Government of Mauritius has put in place incentives applicable to companies engaged in pharmaceutical, medical devices, cosmeceutical/dermatological products and Research & Development/Research Laboratories as follows: –

	Activity	Major Incentives
1	Pharmaceutical products	8-year corporate tax holiday – after period: 3% corporate tax in profits derived from exports of goods
2	Medical Devices, Instruments and products	No registration duty or land transfer
3	Cosmeceutical products	No import duties on equipment & raw materials
4	Dermatological products	No export duties in Mauritius
5	R & D Laboratories	– VAT exemption on construction of medical R&D centers – VAT exemption on plants and equipment – Accelerated depreciation of 50% in respect of capital expenditure incurred on R&D, that is the investment cost is fully amortised in 2 years

For more information, we invite you to contact our Business Development Team by email at bd@juristax.com or call them on + 230 465 55 26.